Literature DB >> 8889727

Comparative activity of azithromycin against clinical isolates of mycobacteria.

B Watt1, A Rayner, G Harris.   

Abstract

Azithromycin exhibited in-vitro activity against 20 clinical isolates of Mycobacterium avium complex for which the MIC90 was 32 mg/L and 22 clinical isolates of other mycobacteria but showed no activity against 20 isolates of Mycobacterium tuberculosis (MIC90 > 128 mg/L) nor against the single isolate of Mycobacterium marinum tested (MIC 128 mg/L). These results suggest that the drug may prove useful for the prophylaxis and treatment of infections due to non-tuberculous mycobacteria, including M. avium complex in patients with AIDS.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8889727     DOI: 10.1093/jac/38.3.539

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  7 in total

1.  In vitro activities of clarithromycin and azithromycin against clinical isolates of Mycobacterium avium-M. intracellulare.

Authors:  L Steele-Moore; K Stark; W J Holloway
Journal:  Antimicrob Agents Chemother       Date:  1999-06       Impact factor: 5.191

2.  Treatment of Non-Tuberculous Mycobacterial Lung Disease.

Authors:  Julie V Philley; Mary Ann DeGroote; Jennifer R Honda; Michael M Chan; Shannon Kasperbauer; Nicholas D Walter; Edward D Chan
Journal:  Curr Treat Options Infect Dis       Date:  2016-10-11

3.  Azithromycin Dose To Maximize Efficacy and Suppress Acquired Drug Resistance in Pulmonary Mycobacterium avium Disease.

Authors:  Devyani Deshpande; Jotam G Pasipanodya; Tawanda Gumbo
Journal:  Antimicrob Agents Chemother       Date:  2016-03-25       Impact factor: 5.191

4.  Chronic Azithromycin Use in Cystic Fibrosis and Risk of Treatment-Emergent Respiratory Pathogens.

Authors:  Jonathan D Cogen; Frankline Onchiri; Julia Emerson; Ronald L Gibson; Lucas R Hoffman; David P Nichols; Margaret Rosenfeld
Journal:  Ann Am Thorac Soc       Date:  2018-06

5.  Network and matrix analysis of the respiratory disease interactome.

Authors:  Benjamin Garcia; Gargi Datta; Gregory P Cosgrove; Michael Strong
Journal:  BMC Syst Biol       Date:  2014-03-22

6.  Network Analysis of Human Genes Influencing Susceptibility to Mycobacterial Infections.

Authors:  Ettie M Lipner; Benjamin J Garcia; Michael Strong
Journal:  PLoS One       Date:  2016-01-11       Impact factor: 3.240

7.  In Vitro Susceptibility of Mycobacterium ulcerans Isolates to Selected Antimicrobials.

Authors:  Enid Owusu; Mercy J Newman; Kwesi K Addo; Phyllis Addo
Journal:  Can J Infect Dis Med Microbiol       Date:  2017-03-14       Impact factor: 2.471

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.